Reduced DNA methylation at the PEG3 DMR and KvDMR1 loci in children exposed to alcohol in utero : a South African Fetal Alcohol Syndrome cohort study by Masemola, Matshane L. et al.
ORIGINAL RESEARCH ARTICLE
published: 10 March 2015
doi: 10.3389/fgene.2015.00085
Reduced DNA methylation at the PEG3 DMR and KvDMR1
loci in children exposed to alcohol in utero: a South
African Fetal Alcohol Syndrome cohort study
Matshane L. Masemola1, Lize van der Merwe2,3, Zané Lombard1,4,5, Denis Viljoen6 and Michèle Ramsay1,4*
1 Division of Human Genetics, National Health Laboratory Service, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand,
Johannesburg, South Africa
2 Department of Statistics, Faculty of Natural Sciences, University of the Western Cape, Cape Town, South Africa
3 Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa
4 Sydney Brenner Institute for Molecular Bioscience, University of the Witwatersrand, Johannesburg, South Africa
5 School of Molecular and Cell Biology, Faculty of Science, University of the Witwatersrand, Johannesburg, South Africa
6 Foundation for Alcohol Related Research, Cape Town, South Africa
Edited by:
Feng C. Zhou, Indiana University
School of Medicine, USA
Reviewed by:
Evan Elliott, Bar-Ilan University,
Israel
Thomas Yang, University of Florida,
USA
*Correspondence:
Michèle Ramsay, Sydney Brenner
Institute for Molecular Bioscience,
University of the Witwatersrand,
9 Jubilee Road, Parktown,
Johannesburg, Gauteng 2050,
South Africa
e-mail: michele.ramsay@wits.ac.za
Fetal alcohol syndrome (FAS) is a devastating developmental disorder resulting from
alcohol exposure during fetal development. It is a considerable public health problem
worldwide and is characterized by central nervous system abnormalities, dysmorphic facial
features, and growth retardation. Imprinted genes are known to play an important role in
growth and development and therefore four imprinting control regions (ICRs), H19 ICR,
IG-DMR, KvDMR1 and PEG3 DMR were examined. It is proposed that DNA methylation
changes may contribute to developmental abnormalities seen in FAS and which persist
into adulthood. The participants included FAS children and controls from the Western
and Northern Cape Provinces. DNA samples extracted from blood and buccal cells were
bisulfite modified, the ICRs were amplified by PCR and pyrosequencing was used to derive
a quantitative estimate of methylation at selected CpG dinucleotides: H19 ICR (six CpG
sites; 50 controls and 73 cases); KvDMR1 (7, 55, and 86); IG-DMR (10, 56, and 84); and
PEG3 DMR (7, 50, and 79). The most profound effects of alcohol exposure are on neuronal
development. In this study we report on epigenetic effects observed in blood which may
not directly reflect tissue-specific alterations in the developing brain. After adjusting for
age and sex (known confounders for DNA methylation), there was a significant difference
at KvDMR1 and PEG3 DMR, but not the H19 ICR, with only a small effect (0.84% lower
in cases; p = 0.035) at IG-DMR. The two maternally imprinted loci, KvDMR1 and PEG3
DMR, showed lower average locus-wide methylation in the FAS cases (1.49%; p < 0.001
and 7.09%; p < 0.001, respectively). The largest effect was at the PEG3 DMR though the
functional impact is uncertain. This study supports the role of epigenetic modulation as
a mechanism for the teratogenic effects of alcohol by altering the methylation profiles of
imprinted loci in a locus-specific manner.
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INTRODUCTION
Alcohol is a potent teratogen with devastating effects on the
developing fetus. The most profound effects of prenatal alcohol
exposure are on neuronal development, resulting in adverse cog-
nitive and behavioral outcomes with lifelong implications, dis-
tinct dysmorphic features (shortened palpebral fissures, smooth
philtrum, and thin vermilion border to the upper lip), and pre-
and postnatal growth retardation (Stratton et al., 1996; Riley and
McGee, 2005; Floyd et al., 2006). The outcomes are collectively
referred to as fetal alcohol spectrum disorders (FASD) and range
in severity with fetal alcohol syndrome (FAS) at the most severe
end of the spectrum (Sokol et al., 2003). FAS is the leading cause
of preventable mental retardation and developmental disability
in the world. It is an international problem that shows no racial
boundaries (Clarren and Smith, 1978; Masotti et al., 2006) and
the consequences of prenatal alcohol exposure represent a major
public health problem worldwide (May and Gossage, 2001; Sokol
et al., 2003; Riley et al., 2011).
The worldwide average prevalence of FAS is estimated at 0.97
per 1000 live births, yet in some communities it is much higher
(Abel and Hannigan, 1995; May and Gossage, 2001; McKinstry,
2005). Notably, the prevalence of FAS in South Africa is one of the
highest reported in the world, at 40.5–46.4 per 1000 children of
school going age in the Western Cape Province (May et al., 2000),
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confirmed in two follow up studies from the same area reporting
an increasing prevalence of 65.2–74.2 (Viljoen et al., 2005) and
68–89.2 per 1000 (May et al., 2007). In addition a study in the
Northern Cape Province reported a similar prevalence of 67.2 per
1000 (Urban et al., 2008).
Fetal alcohol syndrome is a complex multifactorial condition
and although prenatal alcohol exposure is the primary trigger,
twin concordance studies and animal models suggest a significant
genetic susceptibility for the development of FAS (Streissguth and
Dehaene, 1993; Becker et al., 1996). Recent studies have proposed
an epigenetic etiology and supporting evidence for such a mecha-
nism is accumulating (Garro et al., 1991; Haycock, 2009; Ungerer
et al., 2013). Gene expression disturbances can be caused by
changes in DNA methylation, molecular modification of histones
and through RNA interference. These mechanisms work together
to produce a unique, and reversible epigenetic signature that
regulates gene expression through chromatin remodeling. DNA
methylation has been investigated extensively as a mechanism of
alcohol teratogenesis.
Genomic imprinting is an epigenetic phenomenon resulting
in mono-allelic gene expression according to the parent of origin
in a locus-specific manner. It is mediated by differential DNA
methylation and imprinted loci play an important role during
normal development (Jirtle et al., 2000; Rodenhiser and Mann,
2006). The DNA methylation status can be influenced by the
environment leading to a functional impact mediated by changes
in the epigenome (Jirtle and Skinner, 2007). Imprinted genes
are therefore suitable candidates for investigating the effects of
teratogens on disease etiology. Almost all imprinted genes con-
tain differentially methylated regions (DMRs) which serve as a
mark that differentiates the paternal allele from the maternal
allele. Some DMRs which regulate the methylation patterns of
a cluster of imprinted genes are referred to as primary DMRs
or imprinting control regions (ICRs). The CpG methylation at
ICRs is established in the gametes and maintained in somatic
tissues of offspring throughout development (Smallwood and
Kelsey, 2012). Despite this trend, they may still be subject to
tissue-specific effects and extrapolation from the tissue under
investigation should be done with care. On the other hand, the
imprinting of secondary DMRs is established after fertilization
(Geuns et al., 2007). Individual loci may be hyper- or hypomethy-
lated following alcohol exposure. A study by Kaminen-Ahola
et al. (2010) reported that maternal alcohol exposure tended to
induce hypermethylation at the Avy locus, while Haycock and
Ramsay (2009) reported hypomethylation at the H19 ICR in
mouse placenta following in utero alcohol exposure and Stouder
et al. (2011) also showed hypomethylation at the H19 ICR in
the brain and sperm of in utero exposed offspring (Stouder
et al., 2011). A study by Liu et al. (2009) has demonstrated
that alcohol exposure during early neurulation can induce aber-
rant changes in DNA methylation with associated changes in
gene expression in mice. These studies support an epigenetic
mechanism as a contributing factor for the development of fea-
tures observed in FASD. It is widely suggested that the effect is
mediated through the interruption of the one carbon pathway
that is critical in production of the methyl groups in the main-
tenance of DNA methylation (Halsted et al., 2002; Liu et al.,
2009). Alcohol exposure is correlated with reduced DNA methy-
lation through several plausible mechanisms. Firstly acetaldehyde,
a metabolite of alcohol metabolism, inhibits methyltransferase
activity, and secondly, folate deficiency as a result of alcohol
consumption and poor nutrition, reduces the pool of methyl
donors.
In this study we examined quantitative changes in DNA
methylation in blood and buccal cells from individuals with FAS,
compared to unaffected controls, at four ICRs that regulate gene
expression at loci that are important during fetal growth and
development: H19 ICR, KvDMR1, IG-DMR, and PEG3 DMR.
MATERIALS AND METHODS
STUDY PARTICIPANTS AND SAMPLE COLLECTION
The study participants included 87 individuals with a diagnosis
of FAS and 58 controls. All participants were of mixed ancestry,
referred to as “Coloreds” in the South African context, and were
resident in the Western Cape and Northern Cape provinces of
South Africa. The FAS cases were recruited from Wellington in
the Western Cape and De Aar and Upington in the Northern
Cape. They were diagnosed by a team of trained clinicians from
the Division of Human Genetics, NHLS, Braamfontein, Johan-
nesburg, and also the Foundation for Alcohol Related Research
(FARR; http://www.farr-sa.co.za), led by Denis Viljoen. The con-
trol participants were recruited from the Northern Cape and
no phenotype data were collected. The cases and controls were
not age matched. The FAS cases has a median age of 9 years
(range 1–16 years) and the control participants were 17–26
years of age (median age 20 years). Adult participants provided
informed consent and the parents or guardians of minor partici-
pants provided informed consent on their behalf. Ethics approval
for the study was obtained from the University of the Witwa-
tersrand Committee for Research on Human Subjects (Medi-
cal) (Protocol numbers M02/10/41, M03/10/20 and M080548).
Venous blood samples were collected into EDTA by qualified
phlebotomists and buccal swabs were collected by the research
staff.
DNA EXTRACTION FROM BLOOD AND BUCCAL TISSUES
DNA was extracted from whole blood using a manual salting
out method according to a modified protocol from Miller et al.
(1988). The buccal tissue DNA was extracted using the Gentra
Puregene buccal cell kit (Qiagen, Valencia, CA, USA).
DNA BISULFITE MODIFICATION AND PCR AMPLIFICATION
Genomic DNA was bisulfite modified using the EZ-DNA Methy-
lation Gold Kit ™ (Zymo Research, Orange, CA, USA). Published
primer sets and custom designed primer sets were used to amplify
specific regions within the ICRs of four imprinted loci: H19 ICR;
IG-DMR; KvDMR1; and PEG3 DMR. Each locus is described
briefly and the details of the PCR and sequencing primers are
shown in Table 1.
The pre-pyrosequencing PCR step requires that one of the
primers is 5′ biotin labeled. In this study we used a universal biotin
labeled primer (5′-biotin-GACGGGACACCGCTGATCGTTTA-
3′) which was included in the PCR cocktail to generate labeled
DNA fragments (Colella et al., 2003). The sequences of primers
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Table 1 | Locus specific information for PCR amplification and pyrosequencing.
Locus
(contig)
No.
CpG
sites
PCR primers (5′–3′) Amplicon
length (bp)
Annealing
Temp (°C)
Sequencing primer
(5′–3′)
Reference
H19 ICR
(AF087017)
6 Outer reverse
CTTAAATCCCAAACCATAACACTA
217 61.5 TGGTTGTAGTTGTGGAAT Present study
Outer forward
GTATATGGGTATTTTTTGGAGGT
Inner forward
GTATATGGGTATTTTTTGGAGGT
Inner reverse
Tag-ATATCCTATTCCCAAATAA
53
IG-DMR
(A117190)
7 Forward
Tag-TTTATTGGGTTGGGTTTTGTTAG
267 58 Primer 1
CAATTACAATACCACAAAAT
Present study
3 Reverse
AACCAATTACAATACCACAAAATT
Primer 2
CCATAAACAACTATAAACCT
Present study
KvDMR1
(U90095)
7 Forward
TTAGTTTTTTGYGTGATGTGTTTATTA
Reverse
Tag-CCCACAAACCTCCACACC
101 55 TTGYGTGATGTGTTTATTA Bourque et al.
(2010)
PEG3 DMR
(AC006115)
7 Reverse
Tag-CCTATAAACAACCCCACACCTATAC
Forward
TAATGAAAGTGTTTGAGATTTGTTG
272 62 GGGGGTAGTTGAGGTT Boissonnas
et al. (2010)
Tag-5′-biotin-GACGGGACACCGCTGATCGTTTA-3′—universal biotin labeled tag.
that were designed to be biotin labeled therefore had a 23 bp com-
plementary tag sequence added to their 5′ ends for the priming of
the universal biotin labeled primer. These primers are shown in
Table 1 as “tag” primers. Unless specified to the contrary, primer
sets were designed using the PSQ assay design software (Biotage,
Uppsala country, Sweden).
The H19 ICR contains seven CTCF binding sites, of which
the sixth is differentially methylated. The sixth CTCF binding
site was the target region in this study and contains five CpGs,
but the amplified region included one extra CpG which was
also included in the analysis. For the H19 ICR amplification,
nested PCR was used with an outer and an inner PCR primer
sets. The PCR reactions for this region were performed in
triplicate.
The amplified IG-DMR region contains 15 CpGs, but only 10
CpGs were analyzed using two different sequencing primers (1
and 2), where one analyzed three and the other analyzed seven
CpG sites. PCR primers used for amplification of the KvDMR1
are published primers and the amplicon contains seven CpGs,
including a differentially methylated NotI site (Bourque et al.,
2010). The PCR forward primer and pyrosequencing sequencing
primer had a wobble introduced to accommodate an unavoid-
able CpG site in the sequence template that could either be
methylated or unmethylated. The PEG3 DMR amplified region
contains 14 CpGs but only seven CpGs were analyzed. The PCR
assays for IG-DMR, KvDMR1, and PEG3 DMR were run in
duplicate.
PYROSEQUENCING FOR QUANTIFICATION OF DNA METHYLATION
ANALYSIS
DNA methylation of the different amplified ICRs was quantified
by pyrosequencing using the PSQ 96MA system with the Pyro-
Gold SQA reagent kit (Biotage, Uppsala, Uppsala country, Swe-
den). Pyrosequencing assays and sequencing primers (Table 1)
were designed using PSQ Assay Design Software and the sequenc-
ing was done in triplicate (H19 ICR) or duplicate (IG-DMR,
KvDMR1, and PEG3 DMR). The percentage methylation for each
of the CpG sites within the target region was calculated using Pyro
Q-CpG software (Biotage, Uppsala, Uppsala country, Sweden).
Two non-CpG cytosine bases were included in all the pyrose-
quencing assays as internal controls to assess successful bisulfite
conversion. Samples containing >5% unsuccessfully converted
non-CpG cytosines were discarded.
STATISTICAL ANALYSIS
We analyzed methylation data for 145 individuals, 87 FAS cases,
58 controls. Not every individual provided complete data. There
was no age overlap due to the cases being of primary school age
(younger than 17 years old, mean age 9 years) and the controls
being 17 years or older. This means that the age effect (difference
between young and older) cannot be distinguished from the fetal
alcohol (case-control) effect in this study. However, the effect
per additional year of age could be estimated within each group.
Both groups had similar gender distributions, as summarized in
Table 2.
Linear mixed-effects models were used to generate all the
results reported here. These analyses are based on joint mod-
els, where all the original methylation observations (individual
replicates) are put into a single model to simultaneously do the
tests. One advantage is that it avoids some false positive results,
because all the results are adjusted for each other. These models
also enabled us to adjust for different kinds of random variation as
random effects: that between sites, and that between individuals,
and that within individuals (between replicates). Adjusting for
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Table 2 | Summary table for number of samples, sex and age distribution for the different loci tested in the control and case groups.
Controls Cases
Age Sex Age Sex
Locus N Mean (years) (min:max) Male Female N Mean (years) (min:max) Male Female
H19 ICR 50 21 (17:26) 27 23 73 8.7 (1:16) 41 32
KvDMR1 55 21 (17:26) 27 28 86 8.4 (1:16) 46 40
IG-DMR 56 21 (17:26) 29 27 84 8.5 (1:16) 45 39
PEG3 DMR 50 21 (17:26) 25 25 79 8.7 (1:16) 46 33
the variation between individuals is a different way of saying we
adjusted for the correlation between replicates on the same indi-
vidual. After confirming, using linear mixed-effects models, that
age and sex were confounders, all further models were adjusted
for them, as fixed effects. All p-values, effects sizes and standard
errors (SE) come from interaction terms in the models. All results
corresponding to p-values below 0.05 are described as significant,
below 0.01 as highly significant and below 0.001 as very highly
significant.
The observed methylation data are summarized with box plots.
Each box extends from the first quartile to the third quartile
(interquartile range), the line inside the box is at the median,
and the whiskers extend to the non-outlying minimum and max-
imum, respectively. Outliers are shown as open circles. The freely
available environment for statistical computing and graphics, R
(R Core Team, 2014), and R package (Pinheiro et al., 2015), were
used for these analyses.
RESULTS
The 87 FAS cases were recruited from several areas of the Western
Cape and the Northern Cape, whereas the 58 control participants
were mainly recruited from the Northern Cape. There are differ-
ences in the numbers of individuals tested per locus, due to failure
to amplify in specific samples for specific loci. Similar percentages
per sex were tested, 30 (52%) males and 28 (48%) females in the
controls and 47 (54%) males and 40 (46%) females in the cases.
The control participants (N = 58) all donated blood samples
and of the 87 FAS cases, eight donated buccal samples and the
remainder donated blood. A summary for the number of samples,
sex and age distribution at the different loci in the case and control
groups is shown in Table 2.
To address tissue specificity of DNA methylation at an
imprinted locus, we showed that there was no significant differ-
ence in percentage methylation at the H19 ICR locus CpG sites
between buccal and blood samples from 50 random partici-
pants from another study (data not shown). Methylation status
between the two tissues was not assessed at KvDMR1, IG-DMR,
and PEG3 DMR. Based on two previous studies, we concluded
that methylation profiles at these ICRs are unlikely to differ
between the two tissues. Bourque et al. (2010) compared average
methylation profiles at KvDMR1 between blood and saliva tissues
in healthy adults and reported that their methylation patterns
were similar. In addition Woodfine et al. (2011) examined the
methylation patterns of 17 germline DMRs (including H19 ICR,
KvDMR1, IG-DMR, and PEG3 DMR) amongst several somatic
tissues (including brain, breast, colon, heart, kidney, and liver)
and reported that the average methylation did not vary amongst
the tissues. It is therefore unlikely that the origin of the tissue for
the DNA methylation studies is a significant confounder in this
study.
Figure 1 contains box plots summarizing the observed per-
centage methylation at individual CpG sites at all loci (H19
ICR, KvDMR1, IG-DMR, and PEG3 DMR), in controls (CON)
and cases (FAS). Figure 2 contains box plots summarizing the
observed percentage average methylation at each locus: H19 ICR,
KvDMR1, IG DMR, and PEG3 DMR, in controls (CON) and cases
(FAS). It is not possible to visualize the data after correction for
age and sex.
AGE AND SEX AS POTENTIAL CONFOUNDERS IN DNA METHYLATION
STUDIES ON IMPRINTED LOCI
Age and sex are reported confounders in DNA methylation studies
and their effects were investigated in the present study. The results
for sex are summarized in Table 3 and for age in Table 4. The sex
effect was highly significant at PEG3 DMR in FAS cases, where
males had an estimated 1.11% more methylation than females.
In contrast, in controls at PEG3 DMR, males had a significant
estimated 0.84% lower methylation compared to that in females.
However estimated methylation did not differ by sex in control
nor in FAS cases at any of H19 ICR, IG-DMR.A, IG-DMR.B, and
KvDMR1. Since there was a significant difference at one locus, sex
was adjusted for in downstream analyses. It was observed that
IG-DMR has a wide variability in methylation at the different
CpG sites analyzed. Most of the individuals had methylation of
above 70% at CpG 1–5 while CpG site 6–10 have methylation
of about 50%. Therefore IG-DMR was split into two regions for
this analysis: sites 1–5 called IG-DMR.A and sites 6–10 called IG-
DMR.B.
Due to ethical considerations in the selection of control par-
ticipants, the study design was sub-optimal in terms of age. All
cases were below 17 years of age and all controls were 17 years
and above, where the latter were able to give individual informed
consent, but the parents or guardians consented to the participa-
tion of the cases. This means that age is strongly confounded and
that it is not possible to tell whether any differences between cases
and controls are caused by the age difference or not. However, the
effect of age inside each of the groups could and was investigated.
Table 4 shows estimates of the difference in methylation per-
centage over 1 year of age, together with its SE and p-values in
cases and controls.
The largest effects are seen at IG-DMR.A and IG-DMR.B in
FAS cases, where the estimated methylation percentage decreased
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FIGURE 1 | Boxplots summarizing the observed percentage methylation at the CpG sites in H19 ICR, IG-DMR, KvDMR1, and PEG3 DMR in controls
(CON) and cases (FAS).
by 0.43 and 0.38% respectively, for a 1 year increase in age. At
KvDMR1, for every year increase in age, there is a significant
estimated methylation increase of 0.19% in controls but in FAS
cases there is a significant decrease by 0.11%. Again the highly
significant effect is seen at PEG3 DMR in the control group,
where estimated methylation percentage decreases by 0.22% for
every year increase in age. No age effect was observed at H19 ICR
(either in cases or controls), nor at IG-DMR.A and IG-DMR.B
(in controls) nor at PEG3 DMR (in cases). Table 5 summarizes,
for each CpG site, the effect of 1 year of age on methylation,
separately for controls and FAS cases, as well as the estimated
difference between cases and controls in that effect. There are five
CpG sites in IG-DMR, one in KvDMR1, where the effect of age
on methylation is significantly lower in FAS cases and controls.
At IG-DMR sites 2, 5, 6, 8, and 9, as well as at KvDMR1 site 6,
methylation decreased highly significantly with age in FAS cases
but no significant effect was detected in controls. In PEG3 DMR
site 2, the effect was significantly higher in FAS cases than controls.
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FIGURE 2 | Boxplot of observed percentage methylation per locus,
H19 ICR, IG-DMR, KvDMR1, and PEG3 DMR, in controls (CON) and
cases (FAS). A significant difference was detected for H19 ICR
between cases and controls (p = 0.024), but after adjustment for sex
and age this was no longer significant. The estimated methylation
percentage difference between cases and controls at PEG3 DMR was
highly significant (p < 0.001) and remained so after adjustment for age
and sex.
Table 3 | Comparison of methylation within a locus between sexes,
separately in FAS and controls.
Locus Group Effect SE P-value
H19 ICR CON 0.33 0.48 0.495
H19 ICR FAS −0.16 0.40 0.687
IG-DMR1.A CON 0.37 0.46 0.428
IG-DMR1.A FAS 0.18 0.38 0.626
IG-DMR1.B CON −0.45 0.46 0.329
IG-DMR1.B FAS −0.60 0.38 0.112
KvDMR1 CON 0.10 0.39 0.795
KvDMR1 FAS −0.22 0.32 0.490
PEG3 DMR CON −0.84 0.41 0.042
PEG3 DMR FAS 1.11 0.33 0.001
CON, controls; FAS, FAS case; Effect, the estimated percentage difference in
methylation between males and females in the specific group at the specific
locus, using linear mixed-effects models, as described in methods section; SE,
standard error of the effect estimate. Significant: p< 0.05. Analyses are adjusted
for variation between sites and also for variation between individuals and within
individuals as random effects.
In light of these differences, sex and age were adjusted for in
the subsequent analyses to assess differences between FAS cases
and controls.
THE EFFECT OF ALCOHOL ON DNA METHYLATION AT DIFFERENT LOCI
(FAS CASES COMPARED TO UNAFFECTED CONTROLS)
Unadjusted and adjusted results are presented to assess potential
differences in methylation percentages at different CpG sites and
Table 4 | The estimated effect of 1 year of age on % methylation per
locus per group.
Locus Group Effect SE P-value
H19 ICR CON −0.05 0.10 0.634
H19 ICR FAS 0.02 0.06 0.749
IG-DMR.A CON 0.02 0.10 0.861
IG-DMR.A FAS −0.43 0.06 <0.001
IG-DMR.B CON 0.01 0.10 0.920
IG-DMR.B FAS −0.38 0.06 <0.001
KvDMR1 CON 0.19 0.08 0.016
KvDMR1 FAS −0.11 0.05 0.021
PEG3 DMR CON −0.22 0.08 0.008
PEG3 DMR FAS 0.00 0.05 0.948
CON, controls; FAS, FAS case; Effect, estimated percentage difference in
methylation between patients of a specific age and those 1 year younger, in
the specific group at the specific locus, using linear mixed-effects models, as
described in methods section; SE, standard error of the effect. Significant:
p < 0.05. Analysis is adjusted for sex (fixed), CpG sites, individuals and replicates
(random effects).
also across loci, between controls and FAS cases. The random
variation between sites, individuals and replicates per individual
was adjusted for in all analyses.
Table 6 gives a summary of the estimated differences in
CpG methylation between FAS cases and controls (FAS-CON),
per CpG site, unadjusted and adjusted for age and sex. Both
models were adjusted for random variation between and within
individuals.
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Table 5 | The estimated effect of 1 year of age on % methylation per CpG site per locus.
Control group FAS cases
Estimated difference in age effect on
methylation between FAS and CON
Locus Site Age effect SE P-value Age effect SE P-value FAS-CON SE P-value
H19 ICR CpG1 0.02 0.16 0.890 0.03 0.10 0.758 0.01 0.19 0.962
H19 ICR CpG2 0.04 0.16 0.811 0.06 0.10 0.577 0.02 0.19 0.924
H19 ICR CpG3 −0.16 0.16 0.298 0.02 0.10 0.851 0.18 0.19 0.326
H19 ICR CpG5 0.10 0.16 0.522 −0.01 0.10 0.896 −0.11 0.19 0.541
H19 ICR CpG6 −0.09 0.16 0.546 0.08 0.10 0.448 0.17 0.19 0.360
IG-DMR CpG1 −0.05 0.17 0.789 −0.43 0.10 <0.001 −0.38 0.20 0.052
IG-DMR CpG2 −0.19 0.17 0.273 −0.72 0.10 <0.001 −0.53 0.20 0.007
IG-DMR CpG3 0.19 0.17 0.256 −0.02 0.10 0.811 −0.22 0.20 0.273
IG-DMR CpG4 0.17 0.17 0.311 −0.17 0.10 0.089 −0.35 0.20 0.081
IG-DMR CpG5 −0.11 0.17 0.520 −0.95 0.10 <0.001 −0.84 0.20 <0.001
IG-DMR CpG6 −0.02 0.17 0.922 −0.45 0.10 <0.001 −0.43 0.20 0.030
IG-DMR CpG7 0.05 0.17 0.774 −0.25 0.10 0.016 −0.30 0.20 0.134
IG-DMR CpG8 0.03 0.17 0.878 −0.44 0.10 <0.001 −0.47 0.20 0.019
IG-DMR CpG9 −0.04 0.17 0.812 −0.52 0.10 <0.001 −0.48 0.20 0.016
IG-DMR CpG10 −0.03 0.17 0.863 −0.40 0.10 <0.001 −0.37 0.20 0.059
KvdMR CpG1 0.26 0.17 0.122 −0.11 0.10 0.255 −0.37 0.20 0.056
KvdMR CpG2 0.11 0.17 0.513 −0.04 0.10 0.687 −0.15 0.20 0.443
KvdMR CpG3 0.10 0.17 0.562 −0.14 0.10 0.148 −0.24 0.20 0.218
KvdMR CpG4 0.14 0.17 0.412 −0.09 0.10 0.363 −0.23 0.20 0.243
KvdMR CpG5 0.26 0.17 0.126 −0.03 0.10 0.769 −0.29 0.20 0.142
KvdMR CpG6 0.18 0.17 0.284 −0.22 0.10 0.023 −0.40 0.20 0.038
KvdMR CpG7 0.15 0.17 0.380 −0.12 0.10 0.225 −0.27 0.20 0.170
PEG3 DMR CpG1 −0.19 0.17 0.272 0.02 0.10 0.818 0.22 0.20 0.289
PEG3 DMR CpG2 −0.28 0.17 0.115 0.25 0.10 0.017 0.53 0.20 0.010
PEG3 DMR CpG3 −0.03 0.17 0.858 0.09 0.10 0.376 0.12 0.20 0.543
PEG3 DMR CpG4 −0.11 0.17 0.523 0.03 0.10 0.793 0.14 0.20 0.495
PEG3 DMR CpG5 −0.22 0.17 0.201 −0.14 0.10 0.194 0.09 0.20 0.665
PEG3 DMR CpG6 −0.19 0.17 0.284 −0.16 0.10 0.125 0.03 0.20 0.895
PEG3 DMR CpG7 −0.37 0.17 0.033 0.03 0.10 0.799 0.40 0.20 0.050
Effect is the estimated percentage difference in methylation between individuals of a specific age and those 1 year younger, in the specific group at the specific
locus, using linear mixed-effects models, as described in methods section.
At H19 ICR, all six sites, and at IG-DMR sites 2, 5, 6, and
9, the case group had significantly higher methylation than the
control group. However after adjusting for age and sex there was
no longer a significant difference between controls and cases. The
only significant effects detected at KvDMR1, were at sites 4 and
7, where methylation was significantly lower in FAS cases than
controls, after adjustment for age and sex. At PEG3 DMR, across
all CpG sites, estimated methylation was very highly significantly
lower (all p-values < 0.001) in FAS than in controls, with and
without adjustment for age and sex.
The estimated methylation percentage difference between con-
trols and cases across each locus is summarized in Table 7 and
the observed percentage methylation is shown in Figure 2. At
the H19 ICR locus, cases showed a highly significant increased
average methylation compared to the controls, but this was no
longer significant after adjusting for age and sex. At KvDMR1
locus showed a significant lower average methylation after age and
sex were adjusted. In the unadjusted analysis, the average methy-
lation was significantly higher (1.15 and 0.75% respectively) in
cases than controls, however after adjusting for age and sex the
direction of the effect had changed but the reduced methylation
was only significant at region B. The PEG3 DMR also showed a
highly significant difference between cases and controls and the
unadjusted (p< 0.001) and adjusted (p< 0.001) effect sizes were
similar (5.47% lower in cases before adjustment and 7.09% lower
in cases after adjustment).
DISCUSSION
Epigenetic modulation is increasingly studied as an important
mechanism to explain fetal outcome based on environmen-
tal exposures during in utero development, with some effects
lasting into adulthood. This includes maternal diet and expo-
sure to teratogens, like alcohol, but may also include fac-
tors like stress. Since imprinted loci play an important role
in fetal development, cellular differentiation and growth, we
decided to investigate the levels of CpG methylation at four
primary DMRs in children with FAS compared to methylation
in unaffected controls. Our understanding of the relationship
between DNA methylation with regard to sex, age and cell type
remains incomplete, but in addition to inter-individual variation,
it is clear that there are locus-specific effects. It is therefore
expected that teratogens would also display locus-specific effects
explaining their impact on fetal outcome. In addition, tissue-
specific DNA methylation and tissue-specific epigenetic responses
to prenatal alcohol exposure could potentially confound the
interpretation of our study as we examined blood and buccal
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Table 6 | Summary of estimated differential CpG methylation between FAS cases and controls (FAS-CON), per CpG site.
Unadjusted Adjusted for age and sex
Locus Site FAS-CON SE P-value FAS-CON SE P-value
H19 ICR CpG1 1.80 0.5 <0.001 0.23 0.79 0.767
H19 ICR CpG2 1.06 0.5 0.035 −0.49 0.79 0.537
H19 ICR CpG3 1.17 0.5 0.019 −0.42 0.79 0.594
H19 ICR CpG5 1.48 0.5 0.003 −0.05 0.79 0.950
H19 ICR CpG6 1.35 0.5 0.007 −0.16 0.79 0.835
IG-DMR.A CpG1 1.02 0.53 0.054 −0.50 0.81 0.540
IG-DMR.A CpG2 1.07 0.53 0.043 −0.52 0.81 0.520
IG-DMR.A CpG3 0.48 0.53 0.364 −1.01 0.81 0.216
IG-DMR.A CpG4 0.19 0.53 0.724 −1.27 0.81 0.117
IG-DMR.A CpG5 3.05 0.53 <0.001 1.50 0.81 0.065
IG-DMR.B CpG6 1.34 0.53 0.012 −0.21 0.81 0.792
IG-DMR.B CpG7 0.22 0.53 0.679 −1.31 0.81 0.106
IG-DMR.B CpG8 0.68 0.53 0.202 −0.92 0.81 0.258
IG-DMR.B CpG9 1.36 0.53 0.010 −0.22 0.81 0.782
IG-DMR.B CpG10 0.24 0.53 0.646 −1.33 0.81 0.101
KvDMR1 CpG1 0.96 0.53 0.072 −0.53 0.81 0.512
KvDMR1 CpG2 0.28 0.53 0.596 −1.21 0.81 0.138
KvDMR1 CpG3 0.28 0.53 0.595 −1.20 0.81 0.141
KvDMR1 CpG4 −0.17 0.53 0.752 −1.67 0.81 0.040
KvDMR1 CpG5 −0.01 0.53 0.986 −1.43 0.81 0.079
KvDMR1 CpG6 −0.10 0.53 0.851 −1.55 0.81 0.057
KvDMR1 CpG7 −0.60 0.53 0.262 −2.12 0.81 0.009
PEG3 DMR CpG1 −5.34 0.55 <0.001 −6.98 0.83 <0.001
PEG3 DMR CpG2 −5.08 0.55 <0.001 −6.69 0.83 <0.001
PEG3 DMR CpG3 −6.14 0.55 <0.001 −7.73 0.83 <0.001
PEG3 DMR CpG4 −4.74 0.55 <0.001 −6.43 0.83 <0.001
PEG3 DMR CpG5 −5.51 0.55 <0.001 −7.07 0.83 <0.001
PEG3 DMR CpG6 −5.11 0.55 <0.001 −6.67 0.83 <0.001
PEG3 DMR CpG7 −5.35 0.55 <0.001 −6.96 0.83 <0.001
The analysis was unadjusted and adjusted for age and sex. Both models were adjusted for random variation between and within individuals.
Table 7 | Estimated differences in percentage methylation between
cases and controls at each locus.
Unadjusted Adjusted for age and sex
Locus Effect SE P-value Effect SE P-value
H19 ICR 1.36 0.31 <0.001 −0.17 0.41 0.674
IG-DMR1.A 1.15 0.30 <0.001 −0.40 0.40 0.315
IG-DMR1.B 0.75 0.30 0.012 −0.84 0.40 0.035
KvDMR1 0.01 0.25 0.967 −1.49 0.37 <0.001
PEG3 DMR −5.47 0.26 <0.001 −7.09 0.37 <0.001
SE, standard error. Significant: p < 0.05. Analyses were adjusted for variation
between sites and variation between individuals, with and without adjustment
for age and sex.
DNA from the participants, rather than neuronal tissue derived
DNA.
SEX AND AGE DEMONSTRATE LOCUS SPECIFIC METHYLATION
EFFECTS ON SELECTED ICRs
The effect of sex on global DNA methylation and locus-specific
methylation has been reported. Global DNA methylation has a
tendency toward higher methylation levels in males (Fuke et al.,
2004; Shimabukuro et al., 2007). Studies on the effect of sex
on locus-specific methylation have shown both increases and
decreases in DNA methylation (Sandovici et al., 2005; Sarter et al.,
2005; Eckhardt et al., 2006; El-Maarri et al., 2007).
In this study, the effect of sex on methylation was shown to
be significant at only one locus, PEG3 DMR. Interestingly the
effects are modest, but opposite in FAS cases and controls, with
the former showing increased methylation (1.11%) in males and
the latter a decrease of 0.84% in males. It is not clear why the sex
effect on methylation is different in the two groups, but it may be
due to the fact that the data were not adjusted for age when the
analysis was done because it was done as a baseline comparison to
decide if sex needed to be adjusted for in the main analysis. PEG3
DMR average methylation was shown to decrease in controls for
every 1 year increase in age, suggesting that there may be an age
sex interaction at this locus. There was no effect of sex on average
methylation at H19 ICR, KvDMR1, and IG-DMR.
Age is reported to cause a reduction in global DNA methy-
lation and causes dramatic changes in the distribution of 5-
methylcytosine across the genome (Liu et al., 2011). With respect
to specific genes, methylation can either be increased or decreased
depending on the gene investigated (as reviewed by Liu et al.,
2003). Issa et al. (1996) reported that the IGF2 P2-P4 promoter-
associated CpG island is methylated on the silenced maternal
allele in young individuals, however with age this methylation
also appears on the paternal allele resulting in biallelic methy-
lation (indicating an overall increase in methylation with age).
The promoter regions of many genes tend to switch from an
unmethylated to a methylated state resulting in gene silencing
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in an age dependent manner. This includes the promoters of
several tumor and aging related genes (Wilson and Jones, 1983;
Fuke et al., 2004; Liu et al., 2011). The mechanism contributing
to the age dependent changes in global methylation includes a
decrease in the expression of DMNT1 (Lopatina et al., 2002; Liu
et al., 2003). Longitudinal research on age effects that study the
same individuals at several time points is rare (Florath et al.,
2014; Flanagan et al., 2015). In two studies DNA methylation of
participants was examined at two ages only, one where they were
sampled 6 years apart and the other 8 years apart. It is therefore
not yet clear whether age-related changes in methylation at CpG
loci associated with age effects occur linearly with age.
We examined the effect of age on the different CpG sites and
average methylation across each locus, separately in FAS cases
and controls. In the control group, with the exception of PEG3
DMR CpG7, there was no CpG site specific age effect. In the
FAS cases however, eight out of the 10 IG-DMR CpG sites, one
KvDMR1 site and one PEG3 DMR site showed a significant age
effect. With a single exception, methylation in the FAS group
decreased by a modest amount for every additional year of age.
When examining the locus-averaged methylation and the effect
of age, there was a small but significant effect for KvDMR1, but
a larger effect in the FAS cases for IG-DMR (for both region A
and B). This effect was not observed in controls. In contrast, the
controls showed an age effect at the PEG3 DMR. The measure for
an age effect is “difference in methylation per additional year of
age”; however there was no overlap in absolute age between cases
and controls. From our results, it would appear that age effects
are more significant at younger ages (1–16 years) than in older
age groups (17–26), in a locus-specific manner.
In this study age was shown to influence methylation at three
of the four loci investigated. In alignment with our findings,
a study on periconceptional famine exposure (Heijmans et al.,
2008) found that within the age group of 43–70 years, the DNA
methylation at the IGF2 DMR of a 10 year older group was
associated with a 3.6% lower methylation (p= 0.015) in controls.
The magnitude (0.36% per annum) of the effect in their study was
greater than that observed in our study.
Since both sex and age showed some effect on DNA methy-
lation at one or more of the imprinted loci in this study, we
present sex and age adjusted analyses when comparing DNA CpG
methylation between FAS cases and unaffected controls.
THE EFFECT OF IN UTERO ALCOHOL EXPOSURE ON DNA METHYLATION
AT FOUR IMPRINTED LOCI
We assessed the possible effect of maternal alcohol consump-
tion on DNA methylation at H19 ICR, KvDMR1, IG-DMR,
and PEG3 DMR, by comparing methylation levels between
FAS cases and unaffected controls. After adjustment for sex
and age there was no observed correlation with in utero alco-
hol exposure at the CpG site level at two of the imprinted
loci, H19 ICR and IG-DMR. Interestingly, a modest effect
(p = 0.035) of decreased methylation (0.84%) for IG-DMR
Region B was observed in FAS cases. The IG-DMR Region B
shows roughly 50% methylation, in line with a parent of origin
allelic effect whereas Region A had an overall higher methylation
percentage.
The IG-DMR is a good candidate in terms of its potential
biological impact, in line with the features of FAS. The pater-
nally methylated IG-DMR is the primary ICR at the DLK1/GTL2
(MEG3) imprinting domain on human chromosome 14q32,
where it plays an essential role in regulating the monoallelic
expression of several imprinted genes including the paternally
expressed DLK1 and maternally expressed GTL2 genes (Lin et al.,
2003). The methylation on the paternal allele is essential in
maintaining the expression of imprinted genes, because failure
to maintain the paternal methylation has been shown to result
in considerable Dlk repression while Gtl2 expression is increased
(Schmidt et al., 2000).
The DLK1/GTL2 (MEG3) imprinting cluster is a critical region
for the phenotypes associated with both maternal and paternal
uniparental disomy (UPD) of chromosome 14 (Coveler et al.,
2002; Kagami et al., 2005; Temple et al., 2007; Buiting et al., 2008).
Maternal uniparental disomy 14 [Upd(14)mat] and hypomethy-
lation at the paternally imprinted IG-DMR (Ogata et al., 2008)
are characterized by pre- and postnatal growth retardation, devel-
opmental delays, mild to moderate mental retardation, muscular
hypotonia, small hands and feet, premature puberty and truncal
obesity. The locus-averaged methylation of the IG-DMR was
modestly reduced in FAS cases, tending toward hypomethylation
and which may potentially contribute to the growth and neuronal
deficits in affected individuals. The magnitude of alcohol effects
may be tissue specific and may play a more important role in
neurogenesis. These findings merit further study and validation.
After adjustment of sex and age, two KvDMR1 CpG sites (4 and
7) showed significantly decreased DNA methylation in FAS cases
which contributed to a locus-averaged decrease of 1.49% methy-
lation in the KvDMR1. The functional impact of this difference
is not clear. The biggest effect (a decrease of 7.09% methylation
in FAS cases) was observed at the PEG3 DMR. Interestingly,
it is the two maternally imprinted loci, KvDMR1 and PEG3
DMR, which are significantly affected by in utero alcohol expo-
sure and both show a decrease in methylation following alcohol
exposure.
One of the key features of FAS is pre- and post-natal growth
retardation and dysregulation of imprinting at H19 ICR has been
associated with growth disorders (Reik et al., 1995; Gicquel et al.,
2005; Ideraabdullah et al., 2008). The findings of our study are,
however, in agreement with a study done in a mouse model by
Haycock and Ramsay (2009) where they reported no difference in
methylation at the H19 ICR of mouse embryos exposed to alcohol
during the preimplantation period, when compared to unexposed
control embryos. Interestingly H19 ICR hypomethylation was
observed in the mouse placentas suggesting a localized effect
on the extra-embryonic tissue, which could explain the effect
on fetal growth. In two other related studies subtle differential
DNA methylation was observed. Knezovich and Ramsay (2012)
reported a significant decrease in methylation at the H19 ICR in
mouse offspring following preconception paternal alcohol expo-
sure and Downing et al. (2011) reported a subtle decrease in
methylation at the mouse Igf2 DMR1 locus in embryos following
in utero alcohol exposure.
The hypomethylation at KvDMR1 and PEG3 DMR is aligned
to our original hypothesis suggesting that alcohol reduces DNA
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methylation through the one carbon metabolism pathway and its
effect on reducing folate levels. In the next sections the potential
implications of hypomethylation at these loci are explored.
THE FUNCTIONAL IMPACT OF REDUCED KvDMR1 METHYLATION IN
FAS CASES IS UNCLEAR
KvDMR1 CpG site-specific and average locus-wide hypomethy-
lation in response to in utero alcohol exposure would suggest
a loss of methylation on the maternally methylated ICR which
regulates the monoallelic expression of several imprinted genes
located in the CDKN1C/KCNQ1OT1 imprinting domain clus-
ter. This imprinting domain harbors the paternally expressed
non-coding antisense transcript to KCNQ1 called KCNQ1OT1,
and other maternally expressed protein coding genes including
KCNQ1 and CDKNIC1. Loss of imprinting, or hypomethylation,
at the KvDMR1 has been widely implicated in the Beckwith–
Wiedemann syndrome (BWS; Gaston et al., 2001; Diaz-Meyer
et al., 2003; Azzi et al., 2009), a congenital disorder characterized
by pre- and postnatal overgrowth, organomegaly, and a high risk
of childhood tumors (Weksberg et al., 2010). Paradoxically, the
FAS cases showed significant hypomethylation at CpG sites 4 and
7 (1.67 and 2.1%, respectively), yet FAS affected individuals are
growth restricted. It is unclear whether hypomethylation of only
two of the seven CpG sites in this ICR will affect the levels of
expression of the imprinted genes in the cluster and what the
functional effect may be.
To gain further insight into gene regulation at this locus will
require both gene expression and DNA methylation studies to
more fully understand the impact of altered methylation at the
KvDMR1. This is the first study to show the effect of alcohol on
methylation status at KvDMR1 and the findings are counter intu-
itive given that hypomethylation is associated with an overgrowth
phenotype (BWS).
UNDERSTANDING THE ROLE OF ALCOHOL INDUCED
HYPOMETHYLATION AT THE PEG3 IMPRINTED GENE CLUSTER IN THE
PATHOGENESIS OF FAS REQUIRES FURTHER KNOWLEDGE OF THE ICR
CONTROLLED GENE EXPRESSION IN THIS REGION
The PEG3 imprinting cluster is located on human chromosome
19q13.4 and is regulated by a maternally methylated ICR, the
PEG3 DMR. The cluster includes several imprinted genes includ-
ing the paternally expressed 3 gene (PEG3), the imprinted zinc-
finger gene 2 (ZIM2) gene and the USP29 gene, all of which are
paternally expressed. Although these loci are syntenic in mouse
and human, there are some interesting differences regarding their
regulation, their tissue specific expression, and their exon struc-
ture and genomic arrangement. The PEG3 gene is expressed in
embryonic tissues, including the hypothalamus and brain, and in
adult mouse and human brain, but most highly in human ovary,
but not mouse ovary. PEG3 encodes a DNA binding protein based
on its multiple zing finger motifs (Relaix et al., 1996; Iuchi, 2001)
and is an imprinted transcription factor that has multiple target
genes (Thiaville et al., 2013). It has a proposed tumor suppressive
function (Nye et al., 2013) and has been shown to induce p53-
mediated apoptosis in multiple cell types (Yamaguchi et al., 2002).
A mouse knockout model targeting the Peg3 gene has shown that
it is responsible for a variety of phenotypic outcomes including
altered maternal offspring rearing behavior, low birth weight,
alteration in fat tissue storage and synthesis, and lower metabolic
activity (Li et al., 1999; Curley et al., 2004).
We observed that maternal alcohol consumption is correlated
with a significant reduction of ∼7% methylation at the PEG3
DMR in FAS cases. The highly significant decrease in methylation
was observed for all the CpG sites analyzed for this locus and
also for the average methylation across this locus. It is possible
that this change in the PEG3 ICR may affect multiple imprinted
genes in the region. PEG3 is expressed from the paternal allele and
is reciprocally repressed on the maternal allele, suggesting that
alcohol induced demethylation likely affects the maternal allele
thus leading to derepression of the PEG3 gene on the maternal
allele, and therefore biallelic expression of PEG3. This would lead
to an overall increase in PEG3 expression. Several studies have
focussed on the effects of reduced Peg3, but none has explored
the phenotypic outcome of over expression of PEG3.
Gene expression studies, without correlation to their imprint-
ing status, have demonstrated upregulation of PEG3 (as well as
several other genes) in intrauterine growth restriction (IUGR)
placentas (reviewed in Ishida and Moore, 2013). Since IUGR is
a cause of reduced fetal growth, this study supports our finding
that the proposed increase in PEG3 expression could be associated
with a growth restriction phenotype. The role of the PEG3 DMR
in regulating the imprinted gene cluster in humans requires
further investigation.
CONCLUSION
Despite limitations in the study design, including the lack of
age matching between cases and controls, the relatively small
sample size, and the inaccessibility of neuronal tissue, significant
differences in DNA methylation were observed at two primary
DMRs when comparing FAS cases with unaffected controls.
The observed hypomethylation at the KvDMR1 has uncertain
functional impact on gene expression and the FAS phenotype.
The largest epigenetic effect among the loci investigated, was a
locus-averaged 7% reduction in DNA methylation at the PEG3
DMR which was observed across all seven CpG sites. This ICR
orchestrates a complex pattern of gene expression across the
region with reported differences in mouse models compared to
humans. It is proposed that hypomethylation of the PEG3 DMR
would result in an increase in the paternally expressed PEG3 gene.
PEG3 has a DNA binding motif and is considered an imprinted
transcription factor, and therefore its function is most likely
mediated by altered expression of its targets. Although there is
some spatiotemporal congruence of gene expression in line with
the developmental origins of the FAS related phenotype, the effect
and mechanism of altered expression of PEG3 and the other
imprinted genes controlled by the PEG3 DMR remains unclear.
Despite the uncertainty of the functional biological mechanism
of the locus-specific hypomethylation of important ICRs in the
blood of FAS cases, these findings support the role of an epigenetic
mechanism in the development of FAS.
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